PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 26962099-7 2016 Metformin, an AMPK activator, increased phosphorylation of both AQP2 and UT-A1 in rat inner medullary collecting ducts (IMCDs). Metformin 0-9 aquaporin 2 Rattus norvegicus 64-68 26962099-8 2016 Metformin increased the apical plasma membrane accumulation of AQP2, but not UT-A1, in rat IM. Metformin 0-9 aquaporin 2 Rattus norvegicus 63-67 26962099-10 2016 These findings suggest that metformin increases osmotic water permeability by increasing AQP2 accumulation in the apical plasma membrane but increases urea permeability by activating UT-A1 already present in the membrane. Metformin 28-37 aquaporin 2 Rattus norvegicus 89-93 34595852-10 2021 Tissue AQP2 levels decreased with lithium administration but stabilized with metformin treatment. Metformin 77-86 aquaporin 2 Rattus norvegicus 7-11 34595852-12 2021 CONCLUSIONS: Metformin may help protect the kidneys from lithium-induced NDI through the AQP2 regulating effect and a reduction in oxidative stress. Metformin 13-22 aquaporin 2 Rattus norvegicus 89-93 30427219-11 2019 When inner medullary tissue was treated with the PKC activator phorbol dibutyrate (PDBu), the AMPK activator metformin, or both, AQP2 phosphorylation at S261 was decreased with PDBu or metformin alone, but there was no additive effect on phosphorylation with PDBu and metformin together. Metformin 109-118 aquaporin 2 Rattus norvegicus 129-133 30427219-11 2019 When inner medullary tissue was treated with the PKC activator phorbol dibutyrate (PDBu), the AMPK activator metformin, or both, AQP2 phosphorylation at S261 was decreased with PDBu or metformin alone, but there was no additive effect on phosphorylation with PDBu and metformin together. Metformin 185-194 aquaporin 2 Rattus norvegicus 129-133 30427219-11 2019 When inner medullary tissue was treated with the PKC activator phorbol dibutyrate (PDBu), the AMPK activator metformin, or both, AQP2 phosphorylation at S261 was decreased with PDBu or metformin alone, but there was no additive effect on phosphorylation with PDBu and metformin together. Metformin 185-194 aquaporin 2 Rattus norvegicus 129-133 27478876-8 2016 Metformin increased protein abundance of inner medullary urea transporter UT-A1 by 61% and aquaporin 2 (AQP2) by 44% in tolvaptan-treated rats, and immunohistochemistry showed increased membrane accumulation of AQP2 with acute and chronic AMPK stimulation. Metformin 0-9 aquaporin 2 Rattus norvegicus 91-102 27478876-8 2016 Metformin increased protein abundance of inner medullary urea transporter UT-A1 by 61% and aquaporin 2 (AQP2) by 44% in tolvaptan-treated rats, and immunohistochemistry showed increased membrane accumulation of AQP2 with acute and chronic AMPK stimulation. Metformin 0-9 aquaporin 2 Rattus norvegicus 104-108 27478876-8 2016 Metformin increased protein abundance of inner medullary urea transporter UT-A1 by 61% and aquaporin 2 (AQP2) by 44% in tolvaptan-treated rats, and immunohistochemistry showed increased membrane accumulation of AQP2 with acute and chronic AMPK stimulation. Metformin 0-9 aquaporin 2 Rattus norvegicus 211-215